Top

Gepubliceerd in:

01-12-2005 | Artikelen

De rol van heparansulfaatproteoglycanen in de pathogenese van de ziekte van Alzheimer

Auteur: Jack van Horssen

Gepubliceerd in: Neuropraxis | Uitgave 6/2005

Abstract

Mede door de ontwikkeling van antibiotica, uitgebalanceerde voeding en aandacht voor hygiëne is de gemiddelde levensverwachting in de twintigste eeuw drastisch gestegen. Als gevolg hiervan is ook de incidentie van leeftijdsgerelateerde aandoeningen, zoals de ziekte van Alzheimer, toegenomen. Verwacht wordt dat in Nederland tegen het midden van deze eeuw meer dan 300.000 patiënten aan de ziekte van Alzheimer zullen lijden.

vorige artikel De paloc-s: de postacute bewustzijnsschaal voor het vaststellen van het bewustzijnsniveau van mensen met niet-aangeboren hersenletsel

volgende artikel Seksuele motivatie: meer dan dopaminerge stimulatie van het ventrale striatum

Bame, K.J., Danda, J., Hassall, A. & Tumova, S. (1997). Abeta(1-40) prevents heparanase-catalyzed degradation of heparan sulfate glycosaminoglycans and proteoglycans in vitro. A role for heparan sulfate proteoglycan turnover in Alzheimer's disease. J Biol Chem 272, 17005-17011.

Bernfield, M., Gotte, M., Park, P.W., Reizes, O., Fitzgerald, M.L., Lincecum, J. & Zako, M. (1999). Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68, 729-777.

Bernfield, M., Kokenyesi, R., Kato, M., Hinkes, M.T., Spring, J., Gallo, R.L. & Lose, E.J. (1992). Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol 8, 365-393.

Cotman, S.L., Halfter, W. & Cole, G.J. (2000). Agrin binds to beta-amyloïd (Abeta), accelerates abeta fibril formation, and is localized to Abeta deposits in Alzheimer's disease brain. Mol Cell Neurosci 15, 183-198.

Dickson, D.W. (1997a). The pathogenesis of senile plaques. J Neuropathol Exp Neurol 56, 321-339.

Dickson, D.W. (1997b). The pathogenesis of senile plaques. J Neuropathol Exp Neurol 56, 321-339.

Dow, K.E. & Wang, W. (1998). Cell biology of astrocyte proteoglycans. Cell Mol Life Sci 54, 567-581.

Fraser, P.E., Nguyen, J.T., Chin, D.T. & Kirschner, D.A. (1992). Effects of sulfate ions on Alzheimer beta/A4 peptide assemblies: implications for amyloïd fibril-proteoglycan interactions. J Neurochem 59, 1531-1540.

Gervais, F., Chalifour, R., Garceau, D., Kong, X., Laurin, J., Mclaughlin, R., Morissette, C. & Paquette, J. (2001). Glycosaminoglycan mimetics: a therapeutic approach to cerebral amyloïd angiopathy. Amyloïd 8 Suppl 1, 28-35.

Gupta, B.R., Frederickson, R.C.& Brunden, K.R. (1995). Proteoglycan-mediated inhibition of A beta proteolysis. A potential cause of senile plaque accumulation. J Biol Chem 270, 18666-18671.

Iozzo, R.V. (2001b). Series Introduction: Heparan sulfate proteoglycans: intricate molecules with intriguing functions. J Clin Invest 108, 165-167.

Iozzo, R.V. (2001a). Series Introduction: Heparan sulfate proteoglycans: intricate molecules with intriguing functions. J Clin Invest 108, 165-167.

Kisilevsky, R., Lemieux, L.J., Fraser, P.E., Kong, X., Hultin, P.G. & Szarek, W.A. (1995). Arresting amyloïdosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease [see comments]. Nat Med 1, 143-148.

Kisilevsky, R. & Szarek, W.A. (2002). Novel glycosaminoglycan precursors as anti-amyloïd agents part II. J Mol Neurosci 19, 45-50.

Kisilevsky, R., Szarek, W.A., Ancsin, J., Bhat, S., Li, Z. & Marone, S. (2003). Novel Glycosaminoglycan Precursors as Anti-Amyloïd Agents, Part III. J Mol Neurosci 20, 291-298.

Kisilevsky, R., Szarek, W.A., Ancsin, J., Vohra, R., Li, Z. & Marone, S. (2004). Novel glycosaminoglycan precursors as antiamyloïd agents: Part IV. J Mol Neurosci 24, 167-172.

McLaurin, J., Franklin, T., Kuhns, W.J. & Fraser, P.E. (1999a). A sulfated proteoglycan aggregation factor mediates amyloïd-beta peptide fibril formation and neurotoxicity. Amyloïd 6, 233-243.

McLaurin, J., Franklin, T., Zhang, X., Deng, J. & Fraser, P.E. (1999b). Interactions of Alzheimer amyloïd-beta peptides with glycosaminoglycans effects on fibril nucleation and growth. Eur J Biochem 266, 1101-1110.

Miller, J.D., Cummings, J., Maresh, G.A., Walker, D.G., Castillo, G.M., Ngo, C., Kimata, K., Kinsella, M.G., Wight, T.N. & Snow, A.D. (1997). Localization of perlecan (or a perlecan-related macromolecule) to isolated microglia in vitro and to microglia/macrophages following infusion of beta-amyloïd protein into rodent hippocampus. Glia 21, 228-243.

Selkoe, D. J. (1998). The cell biology of beta-amyloïd precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol 8, 447-453.

Selkoe, D.J. (1991). The molecular pathology of Alzheimer's disease. Neuron 6, 487-498.

Shaffer, L.M., Dority, M.D., Gupta-Bansal, R., Frederickson, R.C., Younkin, S.G. & Brunden, K.R. (1995). Amyloïd beta protein (A beta) removal by neuroglial cells in culture. Neurobiol Aging 16, 737-745.

Snow, A.D., Mar, H., Nochlin, D., Kimata, K., Kato, M., Suzuki, S., Hassell, J. & Wight, T.N. (1988). The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am J Pathol 133, 456-463.

Snow, A.D., Mar, H., Nochlin, D., Sekiguchi, R.T., Kimata, K., Koike, Y. & Wight, T.N. (1990a). Early accumulation of heparan sulfate in neurons and in the beta-amyloïd protein-containing lesions of Alzheimer's disease and Down's syndrome. Am J Pathol 137, 1253-1270.

Snow, A.D., Mar, H., Nochlin, D., Sekiguchi, R.T., Kimata, K., Koike, Y., & Wight, T.N. (1990b). Early accumulation of heparan sulfate in neurons and in the beta-amyloïd protein-containing lesions of Alzheimer's disease and Down's syndrome. Am J Pathol 137, 1253-1270.

Snow, A.D., Sekiguchi, R., Nochlin, D., Fraser, P., Kimata, K., Mizutani, A., Arai, M., Schreier, W.A. & Morgan, D.G. (1994). An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloïd in rat brain. Neuron 12, 219-234.

Snow, A.D. & Wight, T.N. (1989). Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloïdoses. Neurobiol Aging 10, 481-497.

Snow, A.D., Willmer, J.P. & Kisilevsky, R. (1987). Sulfated glycosaminoglycans in Alzheimer's disease. Hum Pathol 18, 506-510.

Stoothoff, W.H. & Johnson, G.V. (2005). Tau phosphorylation: physiological and pathological consequences. Biochim Biophys Acta 1739, 280-297.

Van Horssen, J., Kleinnijenhuis, J., Maass, C.N., Rensink, A.A., Otte-Holler, I., David, G., Van den Heuvel, L.P., Wesseling, P., De Waal, R.M. & Verbeek, M.M. (2002c). Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques. Neurobiol Aging 23, 537-545.

Van Horssen, J., Kleinnijenhuis, J., Maass, C.N., Rensink, A.A., Otte-Holler, I., David, G., Van den Heuvel, L.P., Wesseling, P., De Waal, R.M. & Verbeek, M.M. (2002b). Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques. Neurobiol Aging 23, 537-545.

Van Horssen, J., Kleinnijenhuis, J., Maass, C.N., Rensink, A.A., Otte-Holler, I., David, G., Van den Heuvel, L.P., Wesseling, P., De Waal, R.M. & Verbeek, M.M. (2002a).Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques. Neurobiol Aging 23, 537-545.

Van Horssen, J., Otte-Holler, I., David, G., Maat-Schieman, M.L., Van den Heuvel, L.P., Wesseling, P., De Waal, R.M. & Verbeek, M.M. (2001). Heparan sulfate proteoglycan expression in cerebrovascular amyloïd beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloïdosis (Dutch) brains. Acta Neuropathol (Berl) 102, 604-614.

Van Horssen, J., Wesseling, P., Van den Heuvel, L.P., De Waal, R.M. & Verbeek, M.M. (2003). Heparan sulphate proteoglycans in Alzheimer's disease and amyloïd-related disorders. Lancet Neurol 2, 482-492.

Van Horssen, J., Wilhelmus, M. M., Heljasvaara, R., Pihlajaniemi, T., Wesseling, P., De Waal, R. M., and Verbeek, M. M. (2002d) Collagen XVIII: a novel heparan sulfate proteoglycan associated with vascular amyloïd depositions and senile plaques in Alzheimer's disease brains. Brain Pathol 12, 456-462.

Verbeek, M.M., Otte, H., I, van-den-Born, J., Van-den-Heuvel, L.P., David, G., Wesseling, P. & De Waal, R.M. (1999). Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain. Am J Pathol 155, 2115-2125.

Yang, D.S., Serpell, L.C., Yip, C.M., McLaurin, J., Chrishti, M.A., Horne, P., Boudreau, L., Kisilevsky, R., Westaway, D. & Fraser, P.E. (2001). Assembly of Alzheimer's amyloïd-beta fibrils and approaches for therapeutic intervention. Amyloïd 8 Suppl 1, 10-19.

Zhu, H., Yu, J. & Kindy, M.S. (2001). Inhibition of amyloïdosis using low-molecular-weight heparins. Mol Med 7, 517-522.

Titel: De rol van heparansulfaatproteoglycanen in de pathogenese van de ziekte van Alzheimer
Auteur: Jack van Horssen
Publicatiedatum: 01-12-2005
Uitgeverij: Bohn Stafleu van Loghum
Gepubliceerd in: Neuropraxis / Uitgave 6/2005
Print ISSN: 1387-5817
Elektronisch ISSN: 1876-5785
DOI: https://doi.org/10.1007/BF03079066

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 6/2005

Seksuele motivatie: meer dan dopaminerge stimulatie van het ventrale striatum

Damasio's error? De somatic-marker-hypothese onder vuur

Woorden vooraf

Revalideren: theorie en praktijk

De paloc-s: de postacute bewustzijnsschaal voor het vaststellen van het bewustzijnsniveau van mensen met niet-aangeboren hersenletsel